Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804298099> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2804298099 endingPage "e30" @default.
- W2804298099 startingPage "e29" @default.
- W2804298099 abstract "Abstract BACKGROUND Kawasaki disease (KD) is a paediatric systemic vasculitis that can be associated with concomitant viral or bacterial infections. Patients with persistent or recurrent fever 36 hours after the end of intravenous immunoglobulin (IVIG) are considered to be resistant to treatment and are at increased risk for coronary complications. OBJECTIVES However, it is unknown how concomitant infection influences the response to IVIG treatment. The aim of this study was to determine the impact of concurrent infection on the prevalence of IVIG resistance and coronary outcome. DESIGN/METHODS Retrospective study of 154 children (mean age at diagnosis: 3.4 ± 2.8 years) diagnosed with KD, between 2008–2016 in a tertiary paediatric university hospital, of which 59 (38%) had concomitant infection. RESULTS Delay in diagnosis (>10 days of fever) was similar between patients with and without concomitant infection (7% vs 7%, p=0.89). Patients with concomitant infection were more likely to have fever 48 hours after initial treatment (36% vs 20%, p=0.05) and to be treated with a second dose of IVIG (33% vs 18%, p=0.04). Patients with infection had higher C-reactive protein at the time of diagnosis (148 vs 112 mg/L, p=0.04), which persisted after IVIG administration (111 vs 59 mg/L at 48 hours, p=0.003). However, there was no statistically significant difference in the prevalence of coronary artery (CA) complications (coronary artery Z-score > 2.5) between patients with and without concomitant infection (36% vs 39%, p=0.68). CONCLUSION Children with KD and concomitant infection are more likely to have persistent fever and elevated inflammatory markers after treatment requiring a second dose of IVIG. Nevertheless, this is not associated with an increased risk of CA complications. Larger scale studies are needed to help distinguish IVIG resistance from infection in children with persistent fever and guide management of this population. Table/Chart or graphic upload" @default.
- W2804298099 created "2018-06-01" @default.
- W2804298099 creator A5003225216 @default.
- W2804298099 creator A5004231336 @default.
- W2804298099 creator A5018389938 @default.
- W2804298099 creator A5036691032 @default.
- W2804298099 creator A5065567983 @default.
- W2804298099 creator A5076059173 @default.
- W2804298099 creator A5087203960 @default.
- W2804298099 date "2018-05-18" @default.
- W2804298099 modified "2023-10-16" @default.
- W2804298099 title "PROFILE OF RESISTANCE TO IVIG TREATMENT IN PATIENT WITH KAWASAKI DISEASE AND CONCOMITANT INFECTION" @default.
- W2804298099 doi "https://doi.org/10.1093/pch/pxy054.076" @default.
- W2804298099 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5961171" @default.
- W2804298099 hasPublicationYear "2018" @default.
- W2804298099 type Work @default.
- W2804298099 sameAs 2804298099 @default.
- W2804298099 citedByCount "0" @default.
- W2804298099 crossrefType "journal-article" @default.
- W2804298099 hasAuthorship W2804298099A5003225216 @default.
- W2804298099 hasAuthorship W2804298099A5004231336 @default.
- W2804298099 hasAuthorship W2804298099A5018389938 @default.
- W2804298099 hasAuthorship W2804298099A5036691032 @default.
- W2804298099 hasAuthorship W2804298099A5065567983 @default.
- W2804298099 hasAuthorship W2804298099A5076059173 @default.
- W2804298099 hasAuthorship W2804298099A5087203960 @default.
- W2804298099 hasBestOaLocation W28042980991 @default.
- W2804298099 hasConcept C126322002 @default.
- W2804298099 hasConcept C167135981 @default.
- W2804298099 hasConcept C203014093 @default.
- W2804298099 hasConcept C2776015282 @default.
- W2804298099 hasConcept C2776820930 @default.
- W2804298099 hasConcept C2777374719 @default.
- W2804298099 hasConcept C2779134260 @default.
- W2804298099 hasConcept C2779384505 @default.
- W2804298099 hasConcept C2781423770 @default.
- W2804298099 hasConcept C71924100 @default.
- W2804298099 hasConcept C90924648 @default.
- W2804298099 hasConceptScore W2804298099C126322002 @default.
- W2804298099 hasConceptScore W2804298099C167135981 @default.
- W2804298099 hasConceptScore W2804298099C203014093 @default.
- W2804298099 hasConceptScore W2804298099C2776015282 @default.
- W2804298099 hasConceptScore W2804298099C2776820930 @default.
- W2804298099 hasConceptScore W2804298099C2777374719 @default.
- W2804298099 hasConceptScore W2804298099C2779134260 @default.
- W2804298099 hasConceptScore W2804298099C2779384505 @default.
- W2804298099 hasConceptScore W2804298099C2781423770 @default.
- W2804298099 hasConceptScore W2804298099C71924100 @default.
- W2804298099 hasConceptScore W2804298099C90924648 @default.
- W2804298099 hasIssue "suppl_1" @default.
- W2804298099 hasLocation W28042980991 @default.
- W2804298099 hasLocation W28042980992 @default.
- W2804298099 hasOpenAccess W2804298099 @default.
- W2804298099 hasPrimaryLocation W28042980991 @default.
- W2804298099 hasRelatedWork W1997206445 @default.
- W2804298099 hasRelatedWork W2012897021 @default.
- W2804298099 hasRelatedWork W2020433352 @default.
- W2804298099 hasRelatedWork W2036543264 @default.
- W2804298099 hasRelatedWork W2262631021 @default.
- W2804298099 hasRelatedWork W2789141098 @default.
- W2804298099 hasRelatedWork W2991371514 @default.
- W2804298099 hasRelatedWork W3174118272 @default.
- W2804298099 hasRelatedWork W4285504791 @default.
- W2804298099 hasRelatedWork W2592336369 @default.
- W2804298099 hasVolume "23" @default.
- W2804298099 isParatext "false" @default.
- W2804298099 isRetracted "false" @default.
- W2804298099 magId "2804298099" @default.
- W2804298099 workType "article" @default.